Alligator Bioscience AB (STU:7AL) Price-to-Operating-Cash-Flow : (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alligator Bioscience AB Price-to-Operating-Cash-Flow?

As of today (2024-06-06), Alligator Bioscience AB's share price is €0.0977. Alligator Bioscience AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.04. Hence, Alligator Bioscience AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Alligator Bioscience AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:7AL's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.87
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Alligator Bioscience AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.04.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.40% per year.

During the past 10 years, Alligator Bioscience AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 29.40% per year. The lowest was -59.50% per year. And the median was -9.70% per year.

Alligator Bioscience AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Alligator Bioscience AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Price-to-Operating-Cash-Flow Chart

Alligator Bioscience AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Alligator Bioscience AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Alligator Bioscience AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Alligator Bioscience AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alligator Bioscience AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alligator Bioscience AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Alligator Bioscience AB's Price-to-Operating-Cash-Flow falls into.

Alligator Bioscience AB Price-to-Operating-Cash-Flow Calculation

Alligator Bioscience AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0977	/	-0.035
	=

Alligator Bioscience AB's Share Price of today is €0.0977.
Alligator Bioscience AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Alligator Bioscience AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB (STU:7AL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (STU:7AL) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ATORX:Sweden 7AL:Germany

Address

Scheelevagen 2, Medicon Village, Lund, SWE, 223 81

Website

http://www.alligatorbioscience.com

Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB (STU:7AL) Headlines

No Headlines